Nephrology

  • Recognizing a retirement, and a calcium deposition syndrome
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine April 2021, 88 (4) 197-198; DOI: https://doi.org/10.3949/ccjm.88b.04021

    Personnel changes at CCJM, and underrecognition of calcium deposition in the cervical spine.

  • Tumoral calcinosis
    Hiroyuki Yano, MD and Mitsuyo Kinjo, MD, MPH
    Cleveland Clinic Journal of Medicine April 2021, 88 (4) 208-209; DOI: https://doi.org/10.3949/ccjm.88a.20084

    A 47-year-old woman on peritoneal dialysis presented with dyspnea and hip pain.

  • Our evolving understanding of primary aldosteronism
    Ali Mehdi, MD, MEd, FACP, Pratibha Rao, MD, MPH and George Thomas, MD
    Cleveland Clinic Journal of Medicine April 2021, 88 (4) 221-227; DOI: https://doi.org/10.3949/ccjm.88a.20166

    Current screening and confirmatory testing lack sensitivity and carry a poor negative predictive value.

  • Why we publish The Clinical Picture
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine February 2021, 88 (2) 69-70; DOI: https://doi.org/10.3949/ccjm.88b.02021

    Gout remains very common—and often undertreated.

  • Cutaneous digital papules
    Hiroyuki Yano, MD and Mitsuyo Kinjo, MD, MPH
    Cleveland Clinic Journal of Medicine February 2021, 88 (2) 73-74; DOI: https://doi.org/10.3949/ccjm.88a.20063

    Tophi in the finger pads call for aggressive urate-lowering therapy.

  • How should you assess glycemic control if the hemoglobin A1c is inaccurate or uninterpretable?
    Wendy O. Henderson, MD, Mary H. Parker, PharmD, FASHP, FCCP, BCPS, BCCP and Bryan C. Batch, MD, MHS
    Cleveland Clinic Journal of Medicine February 2021, 88 (2) 81-85; DOI: https://doi.org/10.3949/ccjm.88a.19135

    Hemoglobin A1c is the standard but is not perfect. Alternatives are available.

  • The role of SGLT-2 inhibitors in managing type 2 diabetes
    Yumiko Tsushima, MD, M. Cecilia Lansang, MD, MPH and Vinni Makin, MBBS, MD, FACE
    Cleveland Clinic Journal of Medicine January 2021, 88 (1) 47-58; DOI: https://doi.org/10.3949/ccjm.88a.20088

    These drugs improve glycemic control and offer cardiovascular and metabolic benefits.

  • SGLT-2 inhibitors: A new era in managing diabetic kidney disease starts now
    Jonathan J. Taliercio, DO, George Thomas, MD, Georges N. Nakhoul, MD, MEd, Tushar J. Vachharajani, MD and Ali Mehdi, MD, MEd
    Cleveland Clinic Journal of Medicine January 2021, 88 (1) 59-63; DOI: https://doi.org/10.3949/ccjm.88a.20190

    Randomized controlled trials of these new agents had positive outcomes.

  • Air embolism after peripheral IV contrast injection
    Justin Goodwin, MS and Karthik Gnanapandithan, MD, MS, FHM
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 718-720; DOI: https://doi.org/10.3949/ccjm.87a.20001

    As little as 2 to 3 mL of air in the cerebral circulation can be fatal.

  • Optimal surveillance and treatment of renal and splenic artery aneurysms
    Optimal surveillance and treatment of renal and splenic artery aneurysms
    CME article
    Tom Kai Ming Wang, MBCHB, MD(res), FRACP and Milind Y. Desai, MD
    Cleveland Clinic Journal of Medicine December 2020, 87 (12) 755-758; DOI: https://doi.org/10.3949/ccjm.87a.19140-2

    Indications for repair are based on aneurysm location and risk factors for rupture.

Pages